Stay updated on Oral Enzalutamide in Advanced Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Oral Enzalutamide in Advanced Prostate Cancer Clinical Trial page.

Latest updates to the Oral Enzalutamide in Advanced Prostate Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThis update only adds Revision: v3.3.2 and removes Revision: v3.2.0 from the study's version history, with no changes to study data or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe funding/operating-status notice at the top of the page was removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check49 days agoChange DetectedA minor metadata update was made: a new Study Status References entry was added on 2025-10-22 and an entry was removed on 2025-10-17. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check56 days agoChange DetectedUpdate includes a new date stamp and study status tag, replacing an older timestamp. Overall meaning shifts toward current context and status rather than substantive content changes.SummaryDifference0.9%

- Check70 days agoChange DetectedThe page has been updated to announce a government funding lapse affecting operations with a note that NIH Clinical Center is open, plus a version bump to v3.2.0, replacing the prior v3.1.0.SummaryDifference9%

- Check78 days agoChange DetectedThe page now indicates revision v3.1.0 and no longer lists v3.0.2.SummaryDifference0.2%

Stay in the know with updates to Oral Enzalutamide in Advanced Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Enzalutamide in Advanced Prostate Cancer Clinical Trial page.